| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,941,637 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
47,312 |
47,312 |
47,312 |
47,312 |
| Total Sell Value |
$657,637 |
$657,637 |
$657,637 |
$657,637 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
1 |
1 |
1 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2015-08-20 |
4 |
S |
$12.81 |
$128,122 |
D/D |
(10,000) |
9,152 |
|
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2015-08-19 |
4 |
OE |
$1.83 |
$104,900 |
D/D |
50,000 |
217,590 |
|
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2015-08-19 |
4 |
S |
$13.20 |
$246,201 |
D/D |
(18,656) |
19,152 |
|
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2015-08-18 |
4 |
S |
$13.52 |
$202,743 |
D/D |
(15,000) |
1,158 |
|
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2015-08-18 |
4 |
OE |
$2.11 |
$31,650 |
D/D |
15,000 |
16,158 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2015-08-13 |
4 |
S |
$13.56 |
$81,398 |
D/D |
(6,002) |
360,977 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2015-08-13 |
4 |
OE |
$0.56 |
$46,800 |
D/D |
45,000 |
366,979 |
|
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2015-07-31 |
4 |
B |
$2.28 |
$1,742 |
D/D |
764 |
37,808 |
2.66 |
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2015-07-31 |
4 |
B |
$2.28 |
$3,425 |
D/D |
1,502 |
27,985 |
2.66 |
- |
|
| Trizzino John |
SVP, Commercial Operations |
• – – |
2015-07-31 |
4 |
B |
$3.63 |
$18,506 |
D/D |
5,098 |
33,709 |
2.74 |
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2015-07-31 |
4 |
B |
$2.28 |
$2,034 |
D/D |
892 |
1,158 |
2.66 |
- |
|
| Erck Stanley C |
CEO and President |
• • – |
2015-07-31 |
4 |
B |
$2.28 |
$7,312 |
D/D |
3,207 |
100,985 |
2.81 |
- |
|
| Young James F |
Director |
– • – |
2015-06-18 |
4 |
S |
$9.47 |
$473,615 |
D/D |
(50,000) |
375,000 |
|
- |
|
| Boudreaux Gail |
Director |
– • – |
2015-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-17 |
4 |
S |
$9.01 |
$1,376,440 |
I/I |
(152,768) |
2,500,000 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-16 |
4 |
S |
$9.01 |
$2,525,368 |
I/I |
(280,285) |
2,652,768 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-11 |
4 |
S |
$9.00 |
$100,665 |
I/I |
(11,185) |
2,933,053 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-10 |
4 |
S |
$9.01 |
$2,679,349 |
I/I |
(297,375) |
2,944,238 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-09 |
4 |
S |
$8.93 |
$424,452 |
I/I |
(47,531) |
3,241,613 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-08 |
4 |
S |
$8.93 |
$1,841,143 |
I/I |
(206,175) |
3,289,144 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-04 |
4 |
S |
$8.92 |
$585,054 |
I/I |
(65,589) |
3,495,319 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-03 |
4 |
S |
$8.92 |
$3,166,600 |
I/I |
(355,000) |
3,560,908 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-02 |
4 |
S |
$8.90 |
$748,419 |
I/I |
(84,092) |
3,915,908 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-06-01 |
4 |
S |
$8.80 |
$13,200,000 |
I/I |
(1,500,000) |
4,000,000 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2015-05-28 |
4 |
S |
$8.70 |
$17,400,000 |
I/I |
(2,000,000) |
5,500,000 |
|
- |
|
604 Records found
|
|
Page 17 of 25 |
|
|
